Windtree Therapeutics Announces Reverse Stock Split in Strategy to Boost Market Compliance
WARRINGTON, PA — Windtree Therapeutics, Inc. (NASDAQ: WINT), a biotechnology firm, has declared a significant adjustment to its stock structure through a 1-for-18 reverse stock split. This strategic move, set …
Windtree Therapeutics Announces Reverse Stock Split in Strategy to Boost Market Compliance Read More